An interventional study of Prolotherapy and Extracorporeal shock wave therapy (ESWT) in Chronic Rotator Cuff Tendinopathy, sponsored by Mahidol University. Completed at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-22.
Sponsored by Mahidol University · Not applicable, Interventional, and Treatment
To compare the efficacy of dextrose solution injection with ESWT for pain reduction in rotator cuff tendinopathy.
Additionally, secondary objective is to evaluate DASH and active range of motion of shoulder joint
413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.
This study's enrollment of 24 is below the median of 50 across 339 interventional studies indexed under Tendinopathy.
Browse Tendinopathy studies →Mahidol University is the lead sponsor of 730 studies on the registry; 118 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Solution 3.6 mL of 25% dextrose and 0.4 mL xylocaine total 4.0 mL And Solution 3.5 mL of 15% dextrose and 0.8 mL xylocaine total 4.3 mL each site Injection interval week 0, 3 and 6 Ultrasound guided injection Injection into enthesis points
Procedure: Prolotherapy
ESWT Treatment interval week 0, 1 and 2 Energy intensity 0.20-0.25 mJ/mm2 per impulse Frequency 4-5 Hz for 2,000 shocks
Device: Extracorporeal shock wave therapy (ESWT)
Prolotherapy is an injection of a relatively small volume of an irritant or sclerosing solution at sites of painful ligament and/or tendon insertions, and in adjacent joint space over the course of several treatment sessions
Extracorporeal shock wave therapy (ESWT), a kind of physical modalities, generating acoustic pulses, that are high positive pressure amplitudes, subsequently transferring concentrated energy to small focal distant areas of 2-8 mm in diameter
VAS score
Pain reduction VAS
Time frame: Assessment at baseline, three weeks, six weeks, three months and six months after the end of the treatment
Function DASH score
Disabilities of the arm, shoulder and hand
Time frame: Assessment at baseline, three weeks, six weeks, three months and six months after the end of the treatment
Shoulder ROM
Active range of motion: Forward flexion Abduction Internal rotation External rotation Active range of motion: Forward flexion Abduction Internal rotation External rotation Active range of motion: Forward flexion Abduction Internal rotation External rotation
Time frame: Assessment at baseline, three weeks, six weeks, three months and six months after the end of the treatment
Plan to share: No
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mahidol University